SEC Form 4 · accession 0001144204-16-087987
China Biologic Products, Inc. · CBPO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Zhijing Cbpo Liu
Officer — Corporate Vice President
Period of report
Mar 11, 2016
Accepted (ET)
Mar 15, 2016 · 7:10 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369868
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 11, 2016 | S | 282 | $108.00 | D | 718 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents 282 shares of common stock sold on the open market for $108 per share on March 11, 2016. Such sold shares were initially granted to the Reporting Person in the form of restricted stock on February 9, 2015, under the Issuer's 2008 equity incentive plan, and vested on February 10, 2016.